Btr Capital Management Inc Abbott Laboratories Transaction History

Btr Capital Management Inc

$641 Million
Q3 2022

A detailed history of Btr Capital Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Btr Capital Management Inc holds 104,958 shares of ABT stock, worth $12 Million. This represents 1.59% of its overall portfolio holdings.

Number of Shares

104,958

Previous 106,080 1.06%

Holding current value

$12 Million

Previous $11.5 Million 11.89%

% of portfolio

1.59%

Previous 1.65%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 12, 2022	SELL	$96.76 - $112.03 $108,564 - $125,697	-1,122 Reduced 1.06%	104,958 $10.2 Million
Q2 2022 Jul 12, 2022	SELL	$102.07 - $123.37 $84,003 - $101,533	-823 Reduced 0.77%	106,080 $11.5 Million
Q1 2022 May 02, 2022	SELL	$114.02 - $139.04 $4,104 - $5,005	-36 Reduced 0.03%	106,903 $12.7 Million
Q4 2021 Feb 02, 2022	BUY	$115.53 - $141.46 $167,518 - $205,117	1,450 Added 1.37%	106,939 $15.1 Million
Q3 2021 Oct 18, 2021	SELL	$116.66 - $129.06 $233,669 - $258,507	-2,003 Reduced 1.86%	105,489 $12.5 Million
Q2 2021 Aug 02, 2021	BUY	$105.79 - $124.53 $730,268 - $859,630	6,903 Added 6.86%	107,492 $12.5 Million
Q1 2021 Apr 08, 2021	SELL	$108.84 - $128.23 $46,583 - $54,882	-428 Reduced 0.42%	100,589 $12.1 Million
Q4 2020 Jan 12, 2021	SELL	$105.0 - $114.42 $87,360 - $95,197	-832 Reduced 0.82%	101,017 $11.1 Million
Q3 2020 Oct 15, 2020	SELL	$91.64 - $111.29 $202,616 - $246,062	-2,211 Reduced 2.12%	101,849 $11.1 Million
Q2 2020 Jul 23, 2020	SELL	$76.57 - $98.0 $19,065 - $24,402	-249 Reduced 0.24%	104,060 $9.51 Million
Q1 2020 Apr 21, 2020	BUY	$62.82 - $91.86 $140,528 - $205,490	2,237 Added 2.19%	104,309 $8.23 Million
Q4 2019 Jan 17, 2020	SELL	$78.51 - $87.4 $136,685 - $152,163	-1,741 Reduced 1.68%	102,072 $8.87 Million
Q3 2019 Oct 21, 2019	SELL	$81.84 - $88.74 $147,393 - $159,820	-1,801 Reduced 1.71%	103,813 $8.69 Million
Q2 2019 Jul 18, 2019	SELL	$72.88 - $85.0 $132,350 - $154,360	-1,816 Reduced 1.69%	105,614 $8.88 Million
Q1 2019 Apr 04, 2019	SELL	$66.22 - $80.06 $252,695 - $305,508	-3,816 Reduced 3.43%	107,430 $0
Q4 2018 Jan 23, 2019	SELL	$65.56 - $74.27 $312,721 - $354,267	-4,770 Reduced 4.11%	111,246 $8.05 Million
Q3 2018 Oct 04, 2018	SELL	$60.81 - $73.36 $1.11 Million - $1.34 Million	-18,270 Reduced 13.61%	116,016 $8.51 Million
Q2 2018 Aug 01, 2018	SELL	$57.57 - $63.54 $48,070 - $53,055	-835 Reduced 0.62%	134,286 $8.19 Million
Q1 2018 May 01, 2018	BUY	$56.27 - $63.62 $44,284 - $50,068	787 Added 0.59%	135,121 $8.1 Million
Q4 2017 Jan 31, 2018	SELL	$53.68 - $57.47 $64,899 - $69,481	-1,209 Reduced 0.89%	134,334 $7.67 Million
Q3 2017 Oct 27, 2017	BUY	$48.06 - $53.64 $6.51 Million - $7.27 Million	135,543	135,543 $7.23 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Btr Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Btr Capital Management Inc with notifications on news.

Account

Btr Capital Management Inc Abbott Laboratories Transaction History